ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Clinical trial NCT06418711 · TERMINATED

Trial details

NCT number: NCT06418711
Sponsor: Mannkind Corporation
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

MAC Lung Disease Treatment Refractory MAC Lung Disease Mycobacterium Infections, Nontuberculous

Start date: 2024-09-11
Primary completion: 2025-11-10
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.